Course contents

Mebendazole - A Review of Emerging Data as an Anticancer Agent

Prescribers
Pharmacists

Pharmaceutical Compounding

In this presentation we briefly review the overlap between cancer therapy and antiparasitic agents, specifically, mebendazole.  We will discuss proposed mechanism of action of mebendazole's anticancer effects and review existing human trial data on mebendazole. Lastly, a brief discussion of drug polymorphism and its relevance to mebendazole is discussed. 
 English only
  Prescribers, Pharmacists 
Write your awesome label here.

Why should I take this course?

  • Review and understand the overlap between cancer therapy and antiparasitic agents
  • Review existing data on the use of mebendazole in humans as cancer treatment
  • Understand the proposed mebendazole's mechanism of action
  • Evaluate the role of polymorphisms and their relevance to treatment

Course Lesson

Meet your instructor

Sarah Taylor, PharmaD

Sarah attended undergrad at St. Olaf College in Northfield where she majored in chemistry and worked in a lab synthesizing dendrimers for possible use as pharmaceutical delivery molecules. It was there that she first developed an interest in pharmacy. She graduated from St. Olaf and pursued her interest in pharmacy at the University of Minnesota College of Pharmacy. During school, she began working at a compounding pharmacy utilizing her chemistry and pharmacy background to develop formulas for a myriad of pharmaceutical dosage forms and applications. After graduation, she continued to work at the compounding pharmacy for a total of 5 years. She uses this experience to help with her current position as the manager of Fagron Academy. Her favorite types of compounds to make include tablet triturates and gummies.